Modulating Phenotypic Expression of the PRKAG2 Cardiac Syndrome
- 15 January 2008
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 117 (2) , 134-135
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Reversibility of PRKAG2 Glycogen-Storage Cardiomyopathy and Electrophysiological ManifestationsCirculation, 2008
- AMPK alterations in cardiac physiology and pathology: enemy or ally?The Journal of Physiology, 2006
- Bax translocates to mitochondria of heart cells during simulated ischaemia: involvement of AMP-activated and p38 mitogen-activated protein kinasesBiochemical Journal, 2006
- A new mutation in PRKAG2 gene causing hypertrophic cardiomyopathy with conduction system disease and muscular glycogenosisNeuromuscular Disorders, 2006
- Fatal Congenital Heart Glycogenosis Caused by a Recurrent Activating R531Q Mutation in the γ2-Subunit of AMP-Activated Protein Kinase (PRKAG2), Not by Phosphorylase Kinase DeficiencyThe American Journal of Human Genetics, 2005
- Transgenic Mouse Model of Ventricular Preexcitation and Atrioventricular Reentrant Tachycardia Induced by an AMP-Activated Protein Kinase Loss-of-Function Mutation Responsible for Wolff-Parkinson-White SyndromeCirculation, 2005
- Constitutively Active Adenosine Monophosphate–Activated Protein Kinase Regulates Voltage-Gated Sodium Channels in Ventricular MyocytesCirculation, 2003
- Glycogen storage disease as a unifying mechanism of disease in the PRKAG2 cardiac syndromeBiochemical Society Transactions, 2003
- Role of AMP-activated protein kinase in mechanism of metformin actionJournal of Clinical Investigation, 2001
- Temperature regulation in subtropical tree batsComparative Biochemistry and Physiology Part A: Physiology, 1993